|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
|
|---|---|---|---|
| Cash Flows from Operating Activities: | |||
| Net loss | |||
| Adjustments to reconcile net loss to net cash (used in) provided by operating activities: | |||
| Depreciation and amortization | |||
| Stock-based compensation | |||
| Amortization of debt discount | |||
| Change in fair value of bifurcated embedded derivatives | |||
| Impairment of fixed assets | |||
| Impairment of intangibles | |||
| Provision for credit losses | |||
| Changes in operating assets and liabilities: | |||
| Accounts receivable | |||
| Prepaid expenses and other current assets | |||
| Related party receivable/payables, net | |||
| Accounts payable and accrued liabilities | |||
| Other liabilities | |||
| Net cash provided by (used in) operating activities | |||
| Cash Flows from Investing Activities: | |||
| Purchases of property and equipment | |||
| Purchase of intangible assets | |||
| Net cash used in investing activities | |||
| Payments on bridge loan | |||
| Proceeds from bridge loan | |||
| Net change in cash and cash equivalents | |||
| Cash and cash equivalents, beginning of period | |||
| Cash and cash equivalents, end of period | |||
| Supplemental disclosure of cash flow information: | |||
| Cash paid for income taxes | |||
| Cash paid for interest | |||
| Supplemental disclosure of non-cash investing and financing activities: | |||
| Common stock issued in exchange for the purchase of intangibles | |||
| Purchase of intangibles accrued for at period end | |||
| Common stock issued in connection with the conversion of the bridge loan | |||
| Conversion of Loan Principle | |||
| Conversion of Loan Principal | |||
| Conversion of Accrued Interest | |||
| Common stock dividend | |||
| Warrants classified from liabilities to equity | |||
| Derivative exchanged into common stock associated with the bridge loan | |||
| Fair value of warrant and derivative liability issued with debt instrument | |||
| Operating right-of-use assets obtained in exchange for new operating lease liabilities, net | |||
| Common stock issued in connection with repayment of intercompany balance | |||
| Accrued expenses written off associated with intangible asset impairment |
Loading...